93 I studie 3 opretholdt hovedparten af de patienter (77%), som initialt blev randomiseret til 50 mg to gange om ugen og som fik nedsat deres Enbrel dosis til 25 mg to gange om ugen efter 12 uger, deres PASI 75 response til uge 36.
In study 3, the majority of patients (77%) who were initially randomised to 50 mg twice weekly and had their Enbrel dose decreased at week 12 to 25 mg twice weekly maintained their PASI 75 response through week 36.